Synonym |
Thai / English name |
Part Used : ไม่ระบุActivity : CYP3A INDUCTIONSolvent/Active Compound : Ginkgolides BType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 2 nanogram/mLDuration : 72 hType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Ginkgolide B did not affect CYP3A protein expression in vitro.Note : Data incomplete
Part Used : ไม่ระบุActivity : CYP3A INDUCTIONSolvent/Active Compound : Ginkgolides BType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 10 nanogram/mLDuration : 72 hType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Ginkgolide B did not affect CYP3A protein expression in vitro.Note : Data incomplete
Part Used : ไม่ระบุActivity : CYP3A INDUCTIONSolvent/Active Compound : Ginkgolides BType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : 50 nanogram/mLDuration : 72 hType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Ginkgolide B did not affect CYP3A protein expression in vitro.Note : Data incomplete
Part Used : ใบActivity : CYP3A INDUCTIONSolvent/Active Compound : Ginkgo biloba extract (GBE)Type of experiment : humanType of animal : -Type of study : Open trialN(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : Midazolam*/Versed/DormicumDose/Conc.(drug) : -Result : PositiveRemark : The pupose of study was to assess the ability of single midazolam concentrations to predict midazolam AUC in the presence and absence of CYP3A modulation by GBE. Subjects received oral midazolam 8 mg before and after 28 days of GBE administration. The geometric mean raio (90% confidence intervals) of midazolam AUC 0-infinity - GBE / AUC 0-infinity pre - GBE was 0.66 (0.49-0.84) P = .03). Single midazolam concentrations between 2 and 5 hours correctly predicted the reduction in midazolam AUC following GBE exposure, but confidence intervals were generally wide.Note : Data incomplete.